Paolo Santini

7PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionPredictive and prognostic markersFluid-structure interaction and aeroacoustics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 07, 2026
Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

|Jun 30, 2026
Full- versus Reduced-Dose Direct Oral Anticoagulants for Extended Treatment of Cancer-Associated Thrombosis: A Multicenter Retrospective Cohort Study.

|Dec 31, 2025
Delphi Consensus on the Role of Venoactive Nutraceuticals in the Management of Chronic Venous Disease: A Position Statement of the Italian Society of Angiology and Vascular Medicine (SIAPAV).

Giacomo Buso, Paolo Santini, Francesca Ghirardini

|Sep 08, 2025
Letter by Santini and Pola Regarding Article, "Rivaroxaban for 18 Months versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)".

Paolo Santini, Roberto Pola

|May 30, 2025
Current diagnostic and therapeutic approaches for peripheral arterial disease in Italy: a survey among vascular specialists of the Italian society of angiology and vascular medicine (SIAPAV) and general practitioners of the Italian federation of general practitioners (FIMMG).

Paolo Santini, Walter Marrocco, Gianmarco Marrocco

|Feb 19, 2025
The role of Bromelain and Liposomal Vitamin C in the treatment of chronic venous disease.

Giacomo Buso, Paolo Santini, Francesca Ghirardini

Pageof 2

Frequent Collaborators

4 joint publications

Roberto Pola

2 joint publications

Adriana Visonà

2 joint publications

Romeo Martini

1 joint publications

Andrea Lupascu